TRAVERE THERAPEUTICS, INC. Increase (Decrease) in Inventories
TRAVERE THERAPEUTICS, INC. (TVTX) reported Increase (Decrease) in Inventories of $3.45 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-04
- TRAVERE THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2026-06-30 was $2.71M, a 14152.63% increase year-over-year.
- TRAVERE THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2026-03-31 was $742.00K.
- TRAVERE THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2025-12-31 was -$1.18M, a 512.98% decline year-over-year.
- TRAVERE THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2025-09-30 was -$194.00K, a 178.86% decline year-over-year.
- TRAVERE THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2025 was -$5.02M, a 233.02% decline from fiscal 2024.
- TRAVERE THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2024 was $3.77M, a 90.43% decline from fiscal 2023.
- TRAVERE THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2023 was $39.42M, a 3160.55% increase from fiscal 2022.
- TRAVERE THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2022 was $1.21M.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 3 month as first filed | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 6 month as first filed | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 9 month as first filed | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $3.45M 10-Q · filed 2026-08-04 | $2.27M derived: sum of 3 quarters · filed 2026-08-04 | $2.08M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $742.00K 10-Q · filed 2026-05-04 | -$435.00K derived: sum of 2 quarters · filed 2026-05-04 | -$629.00K derived: sum of 3 quarters · filed 2026-05-04 | -$610.00K derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | -$1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$1.37M derived: sum of 2 quarters · filed 2026-02-19 | -$1.35M derived: sum of 3 quarters · filed 2026-08-04 | -$5.02M 10-K · filed 2026-02-19 | ||||
| 2025-09-30 | -$194.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$175.00K derived: sum of 2 quarters · filed 2026-08-04 | -$3.84M 10-Q · filed 2025-10-30 | -$3.55M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$3.65M 10-Q · filed 2026-08-04 | -$3.36M derived: sum of 3 quarters · filed 2026-08-04 | -$3.11M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | -$3.66M 10-Q · filed 2026-05-04 | -$3.38M derived: sum of 2 quarters · filed 2026-05-04 | -$3.13M derived: sum of 3 quarters · filed 2026-05-04 | -$1.72M derived: sum of 4 quarters · filed 2026-05-04 | ||||
| 2024-12-31 | $285.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $531.00K derived: sum of 2 quarters · filed 2026-02-19 | $1.95M derived: sum of 3 quarters · filed 2026-02-19 | $3.77M 10-K · filed 2026-02-19 | ||||
| 2024-09-30 | $246.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $1.66M derived: sum of 2 quarters · filed 2025-10-30 | $3.49M 10-Q · filed 2025-10-30 | $25.88M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-06-30 | $1.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $3.24M 10-Q · filed 2025-08-06 | $25.63M derived: sum of 3 quarters · filed 2026-02-19 | $30.40M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-03-31 | $1.82M 10-Q · filed 2025-05-01 | $24.22M derived: sum of 2 quarters · filed 2026-02-19 | $28.98M derived: sum of 3 quarters · filed 2026-02-19 | $40.73M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2023-12-31 | $22.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $27.16M derived: sum of 2 quarters · filed 2026-02-19 | $38.91M derived: sum of 3 quarters · filed 2026-02-19 | $39.42M 10-K · filed 2026-02-19 | ||||
| 2023-09-30 | $4.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $16.52M derived: sum of 2 quarters · filed 2024-10-31 | $17.03M 10-Q · filed 2024-10-31 | $16.99M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2023-06-30 | $11.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $12.26M 10-Q · filed 2024-08-01 | $13.02M 10-Q · filed 2023-08-03 | $12.22M derived: sum of 3 quarters · filed 2025-02-21 | $11.41M derived: sum of 4 quarters · filed 2025-02-21 | |||
| 2023-03-31 | $510.00K 10-Q · filed 2024-05-06 | $513.00K 10-Q · filed 2023-05-04 | $472.00K derived: sum of 2 quarters · filed 2025-02-21 | -$341.00K derived: sum of 3 quarters · filed 2025-02-21 | $1.56M derived: sum of 4 quarters · filed 2025-02-21 | |||
| 2022-12-31 | -$38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | -$851.00K derived: sum of 2 quarters · filed 2025-02-21 | $1.05M derived: sum of 3 quarters · filed 2025-02-21 | $1.21M 10-K · filed 2025-02-21 | $2.06M 10-K · filed 2023-02-23 | |||
| 2022-09-30 | -$813.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $1.09M derived: sum of 2 quarters · filed 2023-11-07 | $1.25M 10-Q · filed 2023-11-07 | $2.05M 10-Q · filed 2022-10-27 | $750.00K derived: sum of 4 quarters · filed 2024-02-20 | |||
| 2022-06-30 | $1.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $2.06M 10-Q · filed 2023-08-03 | $1.56M derived: sum of 3 quarters · filed 2024-02-20 | $1.18M derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2022-03-31 | $157.00K 10-Q · filed 2023-05-04 | -$340.00K derived: sum of 2 quarters · filed 2024-02-20 | -$724.00K derived: sum of 3 quarters · filed 2024-02-20 | -$23.00K derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2021-12-31 | -$497.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | -$881.00K derived: sum of 2 quarters · filed 2024-02-20 | -$180.00K derived: sum of 3 quarters · filed 2024-02-20 | -$117.00K 10-K · filed 2024-02-20 | $1.81M 10-K · filed 2022-02-24 | |||
| 2021-09-30 | -$384.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $317.00K derived: sum of 2 quarters · filed 2022-10-27 | $380.00K 10-Q · filed 2022-10-27 | $1.63M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-06-30 | $701.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $764.00K 10-Q · filed 2022-08-04 | $2.02M derived: sum of 3 quarters · filed 2023-02-23 | $4.96M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-03-31 | $63.00K 10-Q · filed 2021-05-06 | $1.32M derived: sum of 2 quarters · filed 2023-02-23 | $4.25M derived: sum of 3 quarters · filed 2023-02-23 | $4.17M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $4.19M derived: sum of 2 quarters · filed 2023-02-23 | $4.11M derived: sum of 3 quarters · filed 2023-02-23 | $5.07M 10-K · filed 2023-02-23 | ||||
| 2020-09-30 | $2.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $2.85M derived: sum of 2 quarters · filed 2021-10-29 | $3.81M 10-Q · filed 2021-10-29 | $5.10M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-30 | -$83.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $875.00K 10-Q · filed 2021-07-29 | $2.16M derived: sum of 3 quarters · filed 2022-02-24 | $3.75M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | $958.00K 10-Q · filed 2021-05-06 | $2.25M derived: sum of 2 quarters · filed 2022-02-24 | $3.83M derived: sum of 3 quarters · filed 2022-02-24 | $2.75M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $2.88M derived: sum of 2 quarters · filed 2022-02-24 | $1.79M derived: sum of 3 quarters · filed 2022-02-24 | $1.96M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | $1.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $501.00K derived: sum of 2 quarters · filed 2020-11-05 | $671.00K 10-Q · filed 2020-11-05 | -$947.00K 10-Q · filed 2019-10-30 | $2.02M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2019-06-30 | -$1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | -$918.00K 10-Q · filed 2020-07-31 | $427.00K derived: sum of 3 quarters · filed 2021-03-01 | $1.42M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-31 | $170.00K 10-Q · filed 2020-05-11 | $1.51M derived: sum of 2 quarters · filed 2021-03-01 | $2.51M derived: sum of 3 quarters · filed 2021-03-01 | $2.35M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $2.34M derived: sum of 2 quarters · filed 2021-03-01 | $2.18M derived: sum of 3 quarters · filed 2021-03-01 | $2.77M 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | $995.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $835.00K derived: sum of 2 quarters · filed 2019-10-30 | $1.43M 10-Q · filed 2019-10-30 | $2.81M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-06-30 | -$160.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $433.00K 10-Q · filed 2019-08-06 | $1.82M derived: sum of 3 quarters · filed 2020-02-24 | $1.93M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-03-31 | $593.00K 10-Q · filed 2019-05-07 | $1.98M derived: sum of 2 quarters · filed 2020-02-24 | $2.09M derived: sum of 3 quarters · filed 2020-02-24 | $1.73M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2017-12-31 | $1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $1.49M derived: sum of 2 quarters · filed 2020-02-24 | $1.13M derived: sum of 3 quarters · filed 2020-02-24 | $1.71M 10-K · filed 2020-02-24 | ||||
| 2017-09-30 | $107.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$255.00K derived: sum of 2 quarters · filed 2018-11-01 | $319.00K 10-Q · filed 2018-11-01 | $175.00K derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-06-30 | -$362.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $212.00K 10-Q · filed 2018-08-03 | $68.00K derived: sum of 3 quarters · filed 2019-02-26 | $606.00K derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-03-31 | $574.00K 10-Q · filed 2018-07-06 | $549.00K 10-Q · filed 2017-05-05 | $430.00K derived: sum of 2 quarters · filed 2019-02-26 | $968.00K derived: sum of 3 quarters · filed 2019-02-26 | $840.00K derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2016-12-31 | -$144.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $394.00K derived: sum of 2 quarters · filed 2019-02-26 | $266.00K derived: sum of 3 quarters · filed 2019-02-26 | $568.00K 10-K · filed 2019-02-26 | $306.00K 10-K · filed 2017-03-01 | |||
| 2016-09-30 | $538.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $410.00K derived: sum of 2 quarters · filed 2017-11-07 | $712.00K 10-Q · filed 2017-11-07 | $602.00K derived: sum of 4 quarters · filed 2018-07-06 | ||||
| 2016-06-30 | -$128.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $174.00K 10-Q · filed 2017-08-09 | $64.00K derived: sum of 3 quarters · filed 2018-07-06 | $708.00K derived: sum of 4 quarters · filed 2018-07-06 | ||||
| 2016-03-31 | $302.00K 10-Q · filed 2017-05-05 | $192.00K derived: sum of 2 quarters · filed 2018-07-06 | $836.00K derived: sum of 3 quarters · filed 2018-07-06 | $1.12M derived: sum of 4 quarters · filed 2018-07-06 | ||||
| 2015-12-31 | -$110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-06 | $534.00K derived: sum of 2 quarters · filed 2018-07-06 | $821.00K derived: sum of 3 quarters · filed 2018-07-06 | $1.17M 10-K · filed 2018-07-06 | ||||
| 2015-09-30 | $644.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $931.00K derived: sum of 2 quarters · filed 2016-11-04 | $1.28M 10-Q · filed 2016-11-04 | $1.07M 10-Q · filed 2015-11-06 | $1.40M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-06-30 | $287.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $640.00K 10-Q · filed 2016-08-05 | $757.00K derived: sum of 3 quarters · filed 2017-03-01 | $943.00K derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | $353.00K 10-Q · filed 2016-05-05 | $352.74K 10-Q · filed 2015-05-11 | $470.00K derived: sum of 2 quarters · filed 2017-03-01 | $656.00K derived: sum of 3 quarters · filed 2017-03-01 | $635.90K derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2014-12-31 | $117.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $303.00K derived: sum of 2 quarters · filed 2017-03-01 | $282.90K derived: sum of 3 quarters · filed 2017-03-01 | $282.00K 10-K · filed 2017-03-01 | $282.50K 10-K · filed 2015-03-11 | |||
| 2014-09-30 | $186.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $165.90K derived: sum of 2 quarters · filed 2015-11-06 | $165.00K 10-Q · filed 2015-11-06 | $165.56K 10-Q · filed 2014-11-13 | ||||
| 2014-06-30 | -$20.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$21.00K 10-Q · filed 2015-08-10 | -$21.32K 10-Q · filed 2014-08-14 | |||||
| 2014-03-31 | -$900.00 10-Q · filed 2015-05-11 | |||||||
| 2013-12-31 | $0.00 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |